Expression was confirmed to be significantly different in melanoma compared to the healthy controls, for IL-1Ra (recognized as ILRn by GEPIA2), IL-7, MIP-1a (recognized as CCL3 by GEPIA2), and MIP-1b (recognized as CCL4 by GEPIA2) (see Figure 9). This evidence concerns the gene IL7 and melanoma.